Back
First Trust Nasdaq BuyWrite Income ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
69
FTQI
First Trust Nasdaq BuyWrite Income ETF
Last Price:
20.29
Seasonality Move:
2.22%
Sell
45
VKTX
Viking Therapeutics
Last Price:
63.15
Seasonality Move:
38.04%
Buy
69
First Trust Nasdaq BuyWrite Income ETF (FTQI)
is a Buy
Is First Trust Nasdaq BuyWrite Income ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq BuyWrite Income ETF [FTQI] share price is $20.30. The Score for FTQI is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- FTQI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FTQI Stock Price Chart
What is First Trust Nasdaq BuyWrite Income ETF's stock price today?
-
The First Trust Nasdaq BuyWrite Income ETF share price today is $20.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTQI is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
FTQI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.06 | Sell |
| Chaikin Money Flow: | 4787 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.34 - 20.68) | Sell |
| Bollinger Bands (100): | (19.92 - 20.68) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.92 | Buy |
| Relative Strength Index (14 RSI): | 44.37 | Sell |
| Chaikin Money Flow: | -27799915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.04 - 71.46) | Sell |
| Bollinger Bands (100): | (52.9 - 66.58) | Buy |
FTQI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.43 | Sell |
| 20-day SMA: | 20.55 | Sell |
| 50-day SMA: | 20.37 | Sell |
| 200-day SMA: | 20.28 | Buy |
| 8-day EMA: | 20.41 | Sell |
| 20-day EMA: | 20.47 | Sell |
| 50-day EMA: | 20.4 | Sell |
| 200-day EMA: | 20.19 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.43 | Sell |
| 20-day SMA: | 67.48 | Sell |
| 50-day SMA: | 64.43 | Sell |
| 200-day SMA: | 59.82 | Buy |
| 8-day EMA: | 69.69 | Sell |
| 20-day EMA: | 68.14 | Sell |
| 50-day EMA: | 65.07 | Sell |
| 200-day EMA: | 55.33 | Buy |
First Trust Nasdaq BuyWrite Income ETF Earnings Growth & FTQI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
First Trust Nasdaq BuyWrite Income ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||